Skip to main content

What's Next For CBD Food And Drink In 2019?

Senate Majority Leader Mitch McConnell, a Republican from Kentucky, holds a hemp pen before the start of a signing ceremony for H.R. 2, Agriculture Improvement Act of 2018, at the White House in Washington, D.C., U.S., on Thursday, Dec. 20, 2018. Photographer: Zach Gibson/Bloomberg© 2018 Bloomberg Finance LP

The New Year means new opportunity for CBD food and drink companies.

With industrial hemp legalized in the farm bill, CBD companies look toward increased sales and opportunities in 2019.

The farm bill, signed by President Trump right before the government shutdown, notably included hemp legalization, championed by Sen. Mitch McConnell.

States will create their own regulatory frameworks to be approved by the U.S. Department of Agriculture (USDA.) States that already produce hemp, such as Colorado and Kentucky, will plan significant expansions to meet demand.

The FDA has not yet approved hemp CBD supplements, food and cosmetics on a national scale, but has approved the pharmaceutical Epidiolex, an epilepsy treatment. The decision will likely happen within 18-24 months, according to a report from the Brightfield Group.

Still, CBD companies, including food and drink companies, are gearing up for a boom in sales in 2019. Some even have products for pets.

Colorado-based Weller makes CBD-infused coconut bites. Hemp legalization will allow the company to expand nationwide.Image courtesy of Weller

The founders of Weller, a CBD snack brand based in Colorado, think hemp legalization is a pivotal step for the CBD movement. Their product is currently sold at coffee shops, convenience stores and grocery stores, but legalization will allow nationwide expansion.

“We think that more and more retailers will start integrating CBD products into their stores to make them available to consumers who are eager to try, but have never been reliably educated, or able to find a trusted brand,” co-founder Matt Oscamou said in an email.

Though Coca-Cola’s CBD soda turned out to be a rumor, other existing food and drink companies are ready to capitalize on the trend.

In September, The Alkaline Water Company announced its launch of CBD-infused water. The Arizona-based company, which already sells its Alkaline88 water at Walmart, Kroger, Safeway-Albertsons and CVS, will launch three new versions of its signature product: hemp-derived CBD infused, vitamin-infused CBD and sparkling CBD Alkaline88 waters. The first batch of sparkling CBD water will be available in flavors like grapefruit, coconut, lemon lime, peach mango and raspberry.

But does the water taste like hemp?

“We have worked with a major flavor house and Infusion Biosciences, Inc., who together have masked any hemp flavor profile,” Ricky Wright, CEO of Alkaline Water Company, said in an email.

Incorporating CBD into existing rituals is an easy way to start using it in 2019. Try adding CBD to your coffee routine with products like hemp-infused coffee, water-soluble powder or simple syrup.

Luckily, legalization doesn’t just mean more products, but competition will likely drive down prices too. Also, more health information should become available, helping consumers make smart choices. The synthetic (and not as potent) products will be easier to weed out as more quality hemp becomes available.

A new year of less pain and anxiety can also be a tasty and refreshing one.

Original Article Source: https://www.forbes.com/sites/bethkaiserman/2018/12/29/cbd-food-and-drink-2019/

Comments

Post a Comment

Popular posts from this blog

Could CBD Lead To The Development Of Safer Antipsychotic Medications?

Antipsychotic medications are important for managing a number of different psychiatric ailments, including bipolar disorders, schizophrenia, and even dementia. These drugs can greatly improve the manageability of symptoms that often distort one’s experience of reality. They can also create major mood disruptions and lead to a number of behavioral and emotional difficulties. Antipsychotic and anti-psychosis medications can be life-changing for people with such disorders, enabling them to live more normal and manageable lives without their symptoms taking over. These drugs work by regulating neurotransmitters in the brain so that naturally occurring imbalances and dysfunctions no longer disrupt mental and emotional processes. Often, reaching this outcome is much easier said than done; it can take a lot of time to find courses and combinations of treatments that work. It’s sometimes necessary to make adjustments to find the right balance for the individual and it’s not unusual for outc...
Post a Comment
Read more

A Dozen US Governors Ask Congressional Leaders To Back Federal Marijuana Reform

A bipartisan coalition of 12 governors from states that have legalized medical or recreational cannabis  sent a letter to congressional leaders, asking for their support in getting a major marijuana reform bill through the U.S. House and Senate. The governors of California, Colorado, Maryland, Massachusetts, Nevada, New York, North Dakota, Oregon, Pennsylvania, Utah, Vermont and Washington state are backing  the STATES Act  – which would codify in federal law that marijuana regulations are to be left to the states instead of the federal government – while also seeking protections on banking and tax issues for the MJ industry. “The STATES Act is not about whether marijuana should be legal or illegal; it is about respecting the authority of states to act, lead and respond to the evolving needs and attitudes of their citizens,” the governors wrote. The letter also expressed support for the SAFE Banking Act , which was approved in March by a House committee. Tha...
Post a Comment
Read more

Cannabis Watch: Canopy Growth To Book Charge Of Up To $568 Million As Marijuana Restructuring Continues

Canopy Growth Corp. said early Thursday it was halting a range of operations across three continents and expects its restructuring plans to result in a charge of up to C$800 million (567.9 million) in the fiscal fourth quarter. U.S.-traded shares US:CGC CA:WEED of the cannabis company fell 1.9% in afternoon trading. Canopy said it was selling operations in Africa, curtailing cultivation of hemp in the U.S. and Columbia, and shutting down an indoor production facility in Canada. The announcement will result in 85 job cuts, the company said. “When I arrived at Canopy Growth in January, I committed to conducting a strategic review in order to lower our cost structure and reduce our cash burn,” Canopy Chief Executive David Klein said in a statement. Read: As cannabis industry stays largely quiet on coronavirus, this CEO has been sounding the alarm Canopy’s restructuring announcement was expected by investors, Cowen analyst Vivien Azer wrote in a note to clients Thursday. Azer rate...
Post a Comment
Read more